Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: MRNA

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Insider Trades
  • Markets
  • News
  • Trading Ideas

Amazon, Target And 3 Other Stocks Insiders Are Selling

By Lisa Levin
Today, 10:36 PM
U.S. crude oil futures traded lower this morning on Monday. Investors, meanwhile, focused on some notable insider trades.

AMZN

Read More
2 minute read
  • Biotech
  • General
  • News

Earlier Announced: China Records First Monkeypox Case

By Benzinga Newsdesk
Today, 10:36 PM
https://www.scmp.com/news/china/science/article/3192823/china-records-first-monkeypox-case?utm_term=Autofeed&utm_medium=Social&utm_content=article&utm_source=Twitter#Echobox=1663339580 The infected patient, who had arrived in Chongqing from overseas, developed symptoms while in Covid quarantine

AEMD

Read More
1 minute read
  • News

White House Says New Monkeypox Cases Down 50% Since Early August

By Benzinga Newsdesk
Today, 10:36 PM
- Reuters 

AEMD

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Trading Ideas

Nasdaq Closes Higher But CNN Fear & Greed Index Remains In ‘Fear’ Zone

By Lisa Levin
Today, 10:36 PM
The CNN Money Fear and Greed index remained in the "fear" zone after the U.S. stocks closed slightly higher in choppy trading on Wednesday. The modest gains followed a sharp plunge on Tuesday, when the Dow Jones tumbled more than 1,200 points following the release of August’s consumer price index data.

ADBE

Read More
1 minute read
  • FDA
  • News

‘Moderna open to supplying COVID vaccines to China, CEO says’ -Reuters

By Benzinga Newsdesk
Today, 10:36 PM
https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-believed-pandemic-beginning-that-biontech-violated-patent-ceo-2022-09-14/

FXI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Argus Research Maintains Buy on Moderna, Lowers Price Target to $150

By Benzinga Newsdesk
Today, 10:37 PM
Argus Research analyst Jasper Hellweg maintains Moderna (NASDAQ:MRNA) with a Buy and lowers the price target from $180 to $150.

MRNA

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
Today, 10:37 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ALT

Read More
1 minute read
  • Biotech
  • General
  • News

CMS Says Updated Covid-19 Vaccines Providing Protection Against Omicron Variant Available At No Cost

By Benzinga Newsdesk
Today, 10:37 PM
- Reuters

AZN

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

Peering Into Moderna’s Recent Short Interest

By Benzinga Insights
Today, 10:37 PM
Moderna's (NASDAQ:MRNA) short percent of float has risen 20.0% since its last report. The company recently reported that it has 14.98 million shares sold short, which is 5.16% of all regular shares that are available for trading.

MRNA

Read More
2 minute read
  • Markets
  • Options

Check Out What Whales Are Doing With MRNA

By Benzinga Insights
Today, 10:37 PM
A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 20 strange trades.

MRNA

Posts navigation

Previous 1 … 15 16 17 … 136 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service